10x Science (YC W26) develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development.

Before a drug candidate can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis. Our AI-native platform automates it, giving drug developers the confidence to advance the right candidates and stop the wrong ones early.

We are a team of three scientist-founders from Stanford, MIT, and UC Berkeley who built foundational technology in next-generation protein characterization. We are already working with multiple top-10 pharma companies and have enterprise contracts in motion. We are well-capitalized and focused on building.